Cargando…
Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions
BACKGROUND: The management of metastatic cancer remains a major challenge in cancer therapy worldwide. The targeted delivery of chemotherapeutic drugs through rationally designed formulations is one potential therapeutic option. Notably, excipient-free nanodispersions that are entirely composed of p...
Autores principales: | Wang, Ruoning, Yang, Yujie, Yang, Mengmeng, Yuan, Dandan, Huang, Jinyu, Chen, Rui, Wang, Honglan, Hu, Lihong, Di, Liuqing, Li, Junsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449082/ https://www.ncbi.nlm.nih.gov/pubmed/32847586 http://dx.doi.org/10.1186/s12951-020-00679-2 |
Ejemplares similares
-
Dual-stimuli-responsive TiO(x)/DOX nanodrug system for lung cancer synergistic therapy
por: Dai, Zideng, et al.
Publicado: (2018) -
Cinnamaldehyde-modified chitosan hybrid nanoparticles for DOX delivering to produce synergistic anti-tumor effects
por: Zhou, Zuoqin, et al.
Publicado: (2022) -
Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma
por: Wang, Ruoning, et al.
Publicado: (2021) -
Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer: Circularly permuted TRAIL with Dox in TNBC
por: Liu, Jia, et al.
Publicado: (2023) -
Multi-Stimuli-Responsive DOX Released from Magnetosome for Tumor Synergistic Theranostics
por: Tsai, Ming-Fong, et al.
Publicado: (2020)